Jinyu Youbang Biotech

Jinyu Youbang Biotech, officially Jinyu Youbang Biotechnology (Jiangsu) Co., Ltd., is a leading Chinese veterinary biopharmaceutical company specializing in the research, development, manufacture, and sale of biological products for animal disease prevention and treatment. Established in 2004 and acquired by Jinyu Bio-technology in 2007, the company operates as a wholly-owned subsidiary with advanced manufacturing facilities in Yangzhou, Jiangsu Province. Jinyu Youbang is renowned for its industry-leading baculovirus expression platform, which it leverages to produce high-quality genetic engineering vaccines for swine, poultry, and waterfowl. Its commercial portfolio includes vaccines for porcine reproductive and respiratory syndrome (PRRS), porcine epidemic diarrhea, Newcastle disease, avian influenza, and duck Tembusu virus. The company's state-of-the-art facilities feature multiple GMP-certified production lines and advanced R&D, testing, and animal experimentation centers.